Report an error

Spotted something inaccurate in “SGLT2 Inhibitors Cut ACOS Risk by 30–38% in Largest Network Meta-Analysis”? Tell us what’s wrong and we’ll check it against the original source.

Cancel

This form is for factual corrections. We read every report but cannot reply individually.